Skip to main content

This site is intended for US healthcare professionals only

Woman crossing street with large manipulator looming above tethering her to PTSD symptoms

Understanding the clinical course
of PTSD

The presentation and clinical course of PTSD are variable among individuals, highlighting the heterogeneity of the disorder. Symptoms, duration, and severity can all vary for each individual.

PTSD is the development of characteristic symptoms after exposure to one or more traumatic events. Characteristic symptoms are described by the American Psychiatric Association’s DSM-5 diagnostic criteria as the 4 core symptom clusters of PTSD and may occur soon after exposure to a traumatic event or may be delayed.1-3*

Intrusion image
Intrusion

(re-experiencing)2,3
Avoidance image
Persistent avoidance2,3
Negative image
Negative changes in cognitions and mood2,3
Arousal image
Alterations in arousal and reactivity2,3

Please see the DSM-5 Diagnostic Criteria for the full criteria.

~25% of individuals who develop PTSD experience delayed onset of symptoms1,2,4*

*While symptoms may present anytime after the trauma, delayed onset is defined as only meeting diagnostic criteria ≥6 months after the index event.

Screen for PTSD. Target patient care.

On average, it takes 8.7 years after a traumatic event for a patient to receive a PTSD diagnosis.5† Use this 5-question screening tool designed to help identify probable PTSD in a primary care setting.

Download screener

†Based on a retrospective study in which 273 psychiatrists who had diagnosed and treated ≥1 civilian adult patient with PTSD were provided patient-level information for 687 patients diagnosed from 2016-2020.5

According to the American Psychiatric Association, PTSD symptom recurrence and intensification may occur in response to reminders of the original trauma, ongoing life stressors, or newly experienced traumatic events2

PTSD is commonly a chronic condition6‡

1 year icon

1/3 of patients may recover by 1-year follow-up

10 years icon

1/3 of patients were still symptomatic 10 years after the exposure to the trauma

Based on the 1990 to 1992 National Comorbidity Survey of 5,877 people that included both treated and untreated patients.

Dr. Javanbakht image
An Expert’s Insights

Join Dr. Javanbakht as he shares how training is critical to diagnosing PTSD

Consider the PTSD symptoms within the symptom clusters as seen in the DSM-5

Diagnosis of PTSD can be challenging due to the variable onset of symptoms and the inherent heterogeneity in presentation.7 And patients often seek care for physical symptoms without mentioning psychiatric symptoms or trauma histories.8

Download a PTSD symptom sheet for a quick reference on the representative symptoms associated with each cluster.

Intrusion image
Intrusion (re-experiencing)2,3
  • Recurrent intrusive memories
  • Traumatic nightmares
  • Flashbacks
Avoidance image
Persistent avoidance of stimuli2,3
  • Avoiding trauma-related thoughts and feelings and/or objects, people, or places associated with the trauma
Negative image
Negative alterations in cognitions and mood2,3
  • Distorted beliefs about 
oneself or the world
  • Persistent shame or guilt
  • Emotional numbing
  • Feelings of alienation
  • Inability to recall key details of the trauma
Hyperarousal image
Marked alterations in arousal and reactivity2,3
  • Irritability
  • Hypervigilance
  • Reckless behavior
  • Sleep disturbance
  • Difficulty in concentrating

Screen for PTSD. Target patient care.

Increase PTSD screening across care settings. Use this 5-question screening tool designed to help identify probable PTSD in a primary care setting.

Download screener

Diagnosis of PTSD requires the identification of 1 or more traumatic events2,9

The DSM-5 provides the diagnostic criteria to make a diagnosis of PTSD. View the DSM-5 Criteria for complete diagnostic information.

The traumatic event is defined as an index trauma, which serves as the basis for assessment for severity of PTSD.2,9,10 Instruments used across clinical and research settings for PTSD include:

Clinician-Administered PTSD Scale 5 (CAPS-5)

The CAPS-5 is a structured interview designed to make a categorical PTSD diagnosis, as well as to provide a measure of PTSD symptom frequency and severity based on the 4 symptom clusters. PTSD symptom items are rated on a 5-point scale of severity ranging from 0 (Absent) to 4 (Extreme/‌incapacitating).11 The full interview takes between 45 and 60 minutes.

PTSD Checklist for DSM-5
(PCL-5)

The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of the DSM-5 symptoms of PTSD with a variety of purposes, including monitoring of symptom changes during and/or following treatment, screening for PTSD, and making a provisional PTSD diagnosis.12

These are 2 commonly used PTSD assessment instruments. The VA, APA, and APoA also provide additional tools and descriptions of the available assessment instruments.

Epidemiology icon
Behind the numbers
Understanding the impact of PTSD
Explore the impact
Light icon
Shedding light
Confronting the challenges
of PTSD
Discover the PTSD landscape
Pathophysiology
Inside PTSD
Journey into the pathophysiology
Explore the science
Sign up now

Stay informed with the latest PTSD information and resources

Receive email updates with the latest insights and news in PTSD. Plus, you can access and download complimentary resources.

  • 1.

    Bryant RA, et al. A multisite analysis of the fluctuating course of posttraumatic stress disorder. JAMA Psychiatry. 2013;70:839-846.

  • 2.

    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition.  DSM-5™. American Psychiatric Publishing; 2013.

  • 3.

    Lancaster CL, et al. Posttraumatic stress disorder: overview of evidence-based assessment and treatment. J Clin Med2016;5:E105.

  • 4.

    Smid GE, et al. Delayed posttraumatic stress disorder: systematic review, meta-analysis, and meta-regression analysis of prospective studies. J Clin Psychiatry. 2009;70:1572-1582.

  • 5.

    Davis LL, et al. Patient journey of civilian adults treated for post-traumatic stress disorder – a chart review study. Poster presented at the Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP), May 30-June 2, 2023.

  • 6.

    Kessler RC, et al. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry. 1995;52:1048-1060.

  • 7.

    Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder; Board on the Health of Select Populations; Institute of Medicine. Diagnosis, Course, and Prevalence of PTSD. In: Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Final Assessment. National Academies Press, Washington DC; 2014. Accessed March 2023. https://www.ncbi.nlm.nih.gov/books/NBK224874/?report=reader#_NBK224874_pubdet_

  • 8.

    Greene T, et al. Prevalence, detection and correlates of PTSD in the primary care setting: a systematic review. J Clin Psychol Med Settings. 2016;23:160-180.

  • 9.

    Mann SK, Marwaha R. Posttraumatic stress disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; Updated January 30, 2023.

  • 10.

    Priebe K, et al. Defining the index trauma in post-traumatic stress disorder patients with multiple trauma exposure: impact on severity scores and treatment effects of using worst single incident versus multiple traumatic events. Eur J Psychotraumatol. 2018;9:1486124.

  • 11.

    Weathers FW, et al. The clinician-administered PTSD scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30:383-395.

  • 12.

    US Department of Veterans Affairs. PTSD: National Center for PTSD. PTSD Checklist for DSM-5 (PCL-5). 2023. Accessed December 4, 2023. https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp